Telmisartan Benzimidazole Acidum CAS 152628-03-0 Puritas >99.5% (HPLC) Telmisartan Intermedia 3 Factory
Ruifu Chemical Supple Telmisartan intermedia Cum Puritate
Telmisartan CAS 144701-48-4
Methyl 2-(p-Tolyl)benzoate CAS 114772-34-8
2-(p-Tolyl) Acidum benzoicum CAS 7148-03-0
Telmisartan Benzimidazole Acidum CAS 152628-03-0
Telmisartan Methyl Ester CAS 528560-93-2
Methyl 2-[4-(Bromomethyl)phenyl]benzoate CAS 114772-38-2
Methyl 4-(Butyrylamino) -3-Methyl-5-Nitrobenzoate CAS 152628-01-8
2-n-Propyl-4-Methyl-6-(1-Methylbenzimidazole-2-yl)benzimidazole CAS 152628-02-9
Nomen chemicum | 4-Methyl-2-Propyl-6-Benzimidazolecarboxylic Acid |
Synonyma | Telmisartan Benzimidazole Acidum;Telmisartan Medium 3;4-Methyl-2-n-Propyl-1H-Benzimidazole-6-Acidum carboxylicum;2-n-Propyl-4-Methyl-6-Carboxylate-1H-Benzimidazole;1H-Benzimidazole-4-Methyl-2-propyl-6-Acid carboxylicum;7-Methyl-2-propyl-1H-Benzimidazole-5-Carboxylic Acid |
CAS Number | 152628-03-0 |
CATTUS Number | RF-PI1880 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C12H14N2O2 |
M. Pondus | 218.26 |
Liquescens punctum | 300℃(lit.) |
Density | 1.259±0.06 g/cm3 |
Solubilitas | Solutum in DMSO et Methanolum |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Alba ad Off-White pulveris |
Lepidium sativum (HPLC) | Oportet Reference Standard |
Puritas / Analysis Methodus | >99.5% (HPLC) |
Aqua (auctore Karl Fischer) | <0.50% |
Residere in Ignition | <0.20% |
Unam immunditiam | <0.50% |
Totalis immunditias | <0.50% |
Metalla gravis | <20ppm |
Proton NMR Spectrum | Conformat ut Structure |
Test Standard | Enterprise Standard |
Consuetudinem | Medium Telmisartanum (CAS: 144701-48-4) |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
4-Methyl-2-Propyl-6-Benzimidazolecarboxylic Acidum, quod Telmisartan Benzimidazole Acidum notum est (CAS: 152628-03-0) intermedium magni momenti est Telmisartan (CAS: 144701-48-4).Telmisartan est potentem, diuturnum, non peptidum AT1 angiotensin receptor contrarius.notatur pro: Curatio hypertensionis, ut sanguinem pressura inferiorem.Pressio sanguinis demissio periculum minuit eventus cardiovasculares fatales et nonfatales, imprimis ictus et infarctiones myocardiales.Periculum reductionis in inhibitores aegros ACE inhibitores cardiovasculares (CV) capere non possunt.Solo aut coniuncto cum aliis antihypertensivis generibus ad curationem hypertensionis adhibita.Usus est etiam in curatione nephropathiae diabeticae in aegris hypertensivis cum diabete melliti specie 2 necnon curatione cordis congestivi.